Fullerton Fund Management Co Ltd. acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 1,755 shares of the company’s stock, valued at approximately $292,000.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Eurizon Capital SGR S.p.A. bought a new position in Astera Labs during the 4th quarter valued at $18,708,000. Nordea Investment Management AB bought a new position in Astera Labs during the 4th quarter valued at $2,028,000. Geneva Partners LLC bought a new position in Astera Labs during the 3rd quarter valued at $1,876,000. Numerai GP LLC boosted its stake in Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after purchasing an additional 7,992 shares in the last quarter. Finally, Swedbank AB boosted its stake in Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after purchasing an additional 33,940 shares in the last quarter. 60.47% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on ALAB shares. UBS Group started coverage on Astera Labs in a research note on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price target for the company. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Stifel Nicolaus raised their price objective on Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Finally, Susquehanna raised their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.
Insider Buying and Selling at Astera Labs
In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total transaction of $1,277,046.75. Following the completion of the sale, the director directly owned 60,134 shares of the company’s stock, valued at $21,909,822.90. This trade represents a 5.51% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 2,161,256 shares of company stock worth $459,844,296. 10.40% of the stock is owned by insiders.
Astera Labs Stock Down 7.1%
ALAB opened at $361.71 on Wednesday. The firm has a market cap of $62.00 billion, a PE ratio of 244.40, a P/E/G ratio of 5.15 and a beta of 3.94. The business has a fifty day simple moving average of $247.50 and a 200-day simple moving average of $182.34. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $398.13.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s revenue was up 93.5% compared to the same quarter last year. During the same period last year, the company posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
